PYC Therapeutics (ASX:PYC) has announced encouraging progress with its investigational drug VP-001, designed to treat Retinitis Pigmentosa type 11 (RP11), a severe genetic eye disorder. The company ...
The India diclofenac sodium market is expanding due to rising musculoskeletal disorders, particularly among the elderly.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback